Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion
about
Cell-specific transcriptional regulation of human leukotriene B(4) receptor geneA second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disordersActivation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammationSelectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses5-Lipoxygenase Pathway, Dendritic Cells, and Adaptive ImmunityMechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxinsLipoxins in chronic inflammationResolution of inflammation: a new paradigm for the pathogenesis of periodontal diseasesLipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administrationIdentification of resolvin D2 receptor mediating resolution of infections and organ protectionUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxisPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsAirway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.The scent of a phagocyte: Advances on leukotriene b(4) receptors.Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.Novel anti-inflammatory--pro-resolving mediators and their receptorsSpecialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases.Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis.Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma.Regulation of the inflammatory response in cardiac repairEssential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.Lipoxins: resolutionary road.New insights into eicosanoid biosynthetic pathways: implications for arthritis.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Lipoxins, resolvins and protectins: new leads for the treatment of asthma.Bioactive lipids in pathological retinopathy.Pathophysiology of Myocardial Infarction.Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses.
P2860
Q24676205-A74A0C82-0D76-49A5-8BCB-A0C9C94B7B64Q24676248-0AD40776-E9CF-440C-AB05-501B551F8EA9Q24676421-4D519BEC-3442-4D3D-A7C9-073FD9AD3BB2Q24685948-7BEBA70D-BAD4-4E5C-800C-2BAB270CC6CDQ24804581-27B0E65C-D6B8-4F67-865D-FBEE7B7AA78AQ28182535-755EC05B-A593-4CB7-8787-E12DB7B92143Q28196238-7A222D31-339C-4A47-A7C6-4CE6444D6617Q28206660-9E4F1E9B-96A2-4709-8F7E-0470797BDC85Q28210465-02EA90F8-895D-4171-A4A7-D3670A233D80Q28265395-9DCFF142-A9E2-40D1-96C7-EA6AF2ADAD6CQ28308192-231BFA81-24CA-4DDE-A522-C315A2320EB0Q28344542-ADB48E23-150C-47A9-A862-310B964B6482Q28716294-7F7AFD14-EB3E-42F3-B07A-723E504CEA7DQ29615694-71E2D0BB-15EE-4194-95A0-E7FB9B019F75Q30438572-C333ED2A-699B-452C-AD3E-0D37ED778A8AQ30764311-7F0C847D-BE92-4173-A94F-F50044AD1B91Q31134484-A6FCCE4F-FD35-450A-AA7E-F5FDC4D43196Q33384350-3E4F3E68-1568-4642-A2AA-925C851BBFCEQ33996680-4E5CA9F6-B2D4-476E-AB6E-732304A16288Q34095174-B6E9B003-D0F3-4A27-98A4-8CE0409D4EE5Q34161069-85A83909-870D-4AF5-8E4D-2D6AC9617AFAQ34522097-B792B581-97B1-4070-9FAB-6B0A6D9372F9Q34978977-F8C3EABE-DC1A-4798-AD76-6A20351980E5Q34982051-13C001DE-1933-4D77-861B-4CD062DEAC6BQ35098090-0792AC0C-F730-411D-8C4F-061B28BCB7D3Q35747915-81E3A685-21FD-4E40-AA6B-F7D90A5CC56AQ35875872-A908D8DD-3686-4479-9588-C5D35F205D76Q36376065-682EB88F-EA91-4E34-B8D9-FAC9D2A2319FQ36390428-6347675D-A8B7-447C-ABB0-649EA1E89543Q36948202-51A0B59C-E57F-4806-A278-EB5100F0D895Q36957089-A7770659-6B1D-4B0D-B77B-5FB7D4B1FF2FQ37047016-E5BF56A0-0EEE-4BBB-A2CF-4F757B82175CQ37604436-4D843A3E-81F2-41AB-80FF-AA8F84DBAF60Q37754734-145E1FA1-99BA-44BA-9129-51BDD8393EACQ37995534-2CD43B36-04C7-4896-9998-1D04C070D37DQ38089177-C46E4542-4188-4387-B9CC-70EA5B1A8C50Q38159735-AC26AB8C-F975-4679-8E1F-F84837DAB18AQ38596702-8F72B0D8-337B-4900-B566-0D03D7D0E8B1Q39028149-0B6F5097-4410-4A23-9B08-77D14C351B87Q39148416-088C476D-4DD5-4F0F-B6ED-80EB936FBE21
P2860
Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@ast
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@en
type
label
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@ast
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@en
prefLabel
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@ast
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@en
P2093
P2860
P356
P1476
Leukotriene B4 receptor transg ...... ggered lipoxins in reperfusion
@en
P2093
C N Serhan
J A O'Brien
M W Freeman
P2860
P304
P356
10.1172/JCI7016
P407
P577
1999-08-01T00:00:00Z